During the preovulatory period, the pituitary action of progesterone is biphasic, moving from a severalfold augmentation of the gonadotropin release action of GnRH to a suppression of GnRH efficacy, which occurs in rats over a period of about 12 h, but the extent to which these biphasic effects are dependent on alterations in progesterone receptor (PR) expression is not known. To address this, as well as the localization of PR in cultured rat pituitary cells, we used cells from ovariectomized rats cultured Ϯ 0.2 nM E 2 with acute progesterone treatment on day 3. Northern blot of poly(A ϩ ) RNA extracts showed multiple PR messenger RNA (mRNA) transcripts between 4.8 -10.2 kb; E 2 treatment led to a 5-to 6-fold increase in the predominant PR mRNA transcripts (5.1 and 10.1 kb). In the presence of E 2 , 200 nM progesterone resulted in a decrease in steady-state PR mRNA levels by 3 h of exposure, with the greatest decrease around 6 h (50% of E 2 control) and recovery by 12 h. Similarly treated pituitary cultures were subjected to dual immunofluorescence staining for LH and PR. In the absence of E 2 , PR was undetectable. In the presence of E 2 , essentially all LH-positive cells were positive for PR and only 1-2% of PR-immunopositive cells were negative for LH, possibly reflecting FSH-exclusive gonadotropes. PR staining was predominantly nuclear, but 20 nM progesterone led to a gradual increase in cytoplasmic staining, with the nuclear-to-cytoplasmic ratio decreasing to near unity by 9 -12 h of exposure. In summary, we show for the first time, that PR colocalizes with LH in cultured female rat pituitary cells and that E 2 induces expression of PR mRNA, as well as PR protein, in rat gonadotropes. In the presence of E 2 , progesterone causes a rapid but transient down-regulation of PR message; recovery of PR mRNA is accompanied by an increase in cytoplasmic PR, suggestive of an increase in synthesis. These dynamic changes implicate the gonadotrope PR as having a significant role within the temporal context of the rat preovulatory period. (Endocrinology 140: 2318 -2325, 1999) P ROGESTERONE plays key roles in modulating gonadotropin secretion during the reproductive cycle in the female at the level of the pituitary gland, as well as the hypothalamus (reviewed in Refs. 1-3). In the anterior pituitary, the inhibitory and stimulatory actions of progesterone are a consequence of genomic effects mediated through the progesterone receptor (PR), and therefore, any changes in PR expression and/or PR protein in pituitary cells could have repercussions on LH and FSH output. The basic assumption is that PR colocalizes with pituitary gonadotropes; and indeed, in monkeys, immunocytochemical studies demonstrated that PR localizes in the nuclei of gonadotropes but not lactotropes (4, 5). In rats, a tritiated progestin analog, R5020, was found to concentrate almost exclusively in LH-immunoreactive pituitary cells (6); however, definitive demonstration of simultaneous localization of PR and LH by immunocytochemical studies similar to those in monkeys is lacking for rat pituitary cells.
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Estrogen consistently has been observed to increase the number of PRs in female pituitary tissue from rats and primates (5, (7) (8) (9) (10) (11) (12) and in cultured female rat pituitary cells (13) , based on analysis by steroid binding assays; in addition, estrogen has been reported to increase pituitary PR, as determined by immunoblot analysis (14) . There is much less known about pituitary PR messenger RNA (mRNA) and its regulation by estrogen; but importantly, Bethea et al. (15) report that estrogen treatment increases PR mRNA in monkey anterior pituitary, as assessed by in situ hybridization. However, at present, there is little known regarding the regulation of rat pituitary PR at the level of mRNA. Multiple PR transcripts have been detected in nonpituitary tissue for several species, including the rat (16 -22) , but information is lacking on the multiple PR transcripts and their modulation by estrogen in the pituitary of any species.
The action of progesterone on PR regulation has been found to be tissue-and even cell type-specific within the female reproductive tract, mammary gland, and brain (reviewed in Ref. 23). We have been examining the role of progesterone and the PR in the regulation of LH secretion using an in vitro model of the rat preovulatory gonadotrope (24 -27). During the preovulatory surge, the action of progesterone on gonadotropin secretion is biphasic, moving from a severalfold augmentation of the release action of GnRH to a suppression of the efficacy of GnRH, which occurs in rats over a period of about 12 h, based on in vivo and in vitro studies (1, 24, 28 -31) . The status of the PR during this period, particularly with regard to dynamic changes in expression, is largely unknown. The aims of the present study were to use a cultured female pituitary cell model to define the colocalization of PR with gonadotropes and to determine the effect of 17␤-estradiol (E 2 ) and progesterone on the PR mRNA levels and PR protein within the temporal context of the rat preovulatory period. Part of this study has been presented in preliminary form (32).
Materials and Methods Materials
Adult, female Sprague Dawley rats (Simonsen, Gilroy, CA) were maintained in controlled light conditions (14 h light, 10 h dark). Media and sera for cell culture were as described previously (24). Progesterone was obtained from Calbiochem (San Diego, CA); E 2 was from Sigma Chemical Co. (St. Louis, MO). Steroids were prepared as stock solutions in ethanol. General chemicals were from either Sigma Chemical Co. or Fisher Scientific International, Inc. (Pittsburgh, PA).
Pituitary cell culture
Rats were ovariectomized and maintained for 2 weeks, after which pituitaries were removed after CO 2 narcosis and decapitation. Anterior pituitary cells, obtained by trypsin dispersion (day 0), were cultured in Eagle's MEM containing d-valine, 0.2 mm kanamycin sulfate, 10% charcoal-treated FBS (FBS-CT), plus or minus 0.2 nm E 2 in a humidified atmosphere of 5% CO 2 in air, as described (24). Residual steroid concentrations in the FBS-CT were 10 pm for progesterone and less than 1 pm for E 2 , as determined by RIA. On day 2, cells were changed to fresh media.
Northern blot experiments
For PR mRNA studies, pituitary cells were plated at 3-4 ϫ 10 6 in 60-mm dishes. On day 3, the cells were changed to serum-free media containing 1 mg/ml BSA and plus or minus E 2 , as appropriate. For some of the cells, the medium included 200 nm progesterone for different periods (from 3-12 h). Termination was accomplished by rinsing the cells in cold PBS and extracting total RNA using guanidine thiocyanate, by the method of Chomczynski and Sacchi (33). For comparison, anterior pituitary and uterus were removed from an adult rat after CO 2 narcosis and decapitation; the tissues were trimmed and immediately frozen in liquid N 2 and stored at Ϫ70 C until processed for total RNA as above. For all groups, poly(A ϩ ) RNA was isolated from total RNA using oligo(dt)-cellulose (New England Biolabs, Inc., Beverly, MA) minicolumns with a bed vol of 0.23 ml. Northern blotting was performed as described by Sambrook et al. (34) . Briefly, RNA was separated on formaldehyde agarose gels and transferred overnight onto Duralon-UV membrane and cross-linked with a UV Stratalinker (Stratagene, La Jolla, CA). The single-stranded [␣-32 P]deoxycytidine triphosphate-labeled probe was generated by assymetric (single-primer) PCR from an approximately 0.8-kb complementary DNA (cDNA) fragment from the hormone binding domain of the mouse PR (20). Prehybridization and hybridization were carried out in QuickHyb (Stratagene) at 68 C followed by washes in 2 ϫ saline-sodium citrate (SSC) (20 ϫ SSC stock ϭ 3 m NaCl, 0.3 m sodium citrate, pH 7.0) with 0.1% SDS at room temperature and a wash at 60 C in 0.2 ϫ SSC/0.1% SDS. Message size was determined by comparison with migration of an RNA ladder (0.24 -9.5 kb; Gibco BRL, Grand Island, NY), run in an adjacent lane, transferred, and stained with methylene blue. For normalization to RNA loading, the membranes were stripped and rehybridized using a mouse actin probe generated by random priming using a kit from Amersham Pharmacia Biotech (Piscataway, NJ). Blots were analyzed by phosphorimaging (Molecular Imager Scanner, Bio-Rad Laboratories, Inc., Richmond, CA) and then subjected to autoradiography (X-OMAT, Eastman Kodak Co., Rochester, NY).
Immunofluorescence experiments
For LH and PR dual immunocytochemistry experiments, cells were plated at 6 ϫ 10 4 on poly-l-lysine-coated glass coverslips inserted into 22-mm wells. On day 3, the cells were changed to serum-free media containing 1 mg/ml BSA and plus or minus E 2 , as appropriate. For some of the cells, the medium included 20 nm progesterone for varying periods (from 3-12 h). Termination was accomplished by rinsing the cells in PBS at room temperature, followed by fixation with methanol:acetone (1:1) for 7 min at Ϫ20 C; fixed cells were stored in PBS at 4 C until stained. Immunofluorescence staining was carried out at room temperature by successive incubation of the coverslips in the following solutions: 1) 5% normal goat serum (NGS; Vector Laboratories, Inc., Burlingame, CA), 1 h; 2) anti-LH (1:500) and anti-PR (1:500), 2 h; 3) PBS-0.1% BSA (PBSA) washes ϫ 3; 4) 5% NGS, 30 min; 5) tetramethyl rhodamine isothiocyanate (TRITC) conjugated goat antimouse IgG (1:100, Sigma Chemical Co.), 1 h; 6) PBSA washes ϫ 3; 7) fluorescein isothiocyanate (FITC)-labeled goat antirabbit IgG (1:160; Sigma Chemical Co.), 1 h; 8) PBSA washes ϫ 3; and 9) distilled water wash and mount using Vectashield mounting medium containing the nuclear dye, 4,6-diamidino-2-phenylindole (DAPI; Vector Laboratories, Inc.). As controls, either or both of the primary antibodies were omitted for some coverslips. All antibodies were diluted in 5% NGS. Mouse monoclonal antibody 518B7 to bovine LH␤ (35) was provided by Jan Roser (University California, Davis). The polyclonal antibody used for analysis of PR is against a synthetic peptide corresponding to amino acids 376 -394, selected from the amino-terminal half of the mouse PR sequence (20), and reacts with both the A and B forms of murine PR (36).
Immunofluorescence analysis
Immunofluorescence was viewed using either a 25ϫ or 40ϫ objective on a Leitz Orthoplan microscope equipped with a multiband pass filter photometer and a Leitz Vario Orthomat2 camera (Leico Microsystems, Inc., Deerfield, IL). Photographs of DAPI-, FITC-, and TRITC-labeled cells were taken using Kodak Ektachrome ASA400 film (Eastman Kodak Co., Rochester, NY); the photographic slides were scanned at high resolution to generate computer images [Photoshop (Adobe Systems, Inc., San Jose, CA)]. The percent of LH-and PR-positive cells was determined by counting DAPI-stained cells, FITC-labeled cells, and TRITC-labeled cells in parallel projected photographic slides and in parallel Photoshop images. From 1-3 fields were examined for each coverslip, and each field was analyzed independently by two individuals.
Intensity analysis. The quantitation of PR staining intensity in the nucleus, as distinct from the cytoplasm, was determined on TIFF images exported from Photoshop; cells were analyzed using Scion Image (Scion Corp., Frederick, MD). The cohort of coverslips used for this analysis had been stained and photographed all within the same 3-day period. Photographs were obtained at the same magnification and light exposure for all fields; the exposure time was allowed to vary to adjust for timedependent loss of fluorescence and photobleaching. Because one objective was a comparison of PR staining intensity in the two compartments across treatment groups, it was important to minimize, as much as possible, the interference caused by subtle variations in staining reagents, fluorescence stability, and photographic exposures that might occur over time. Because the nuclear-to-cytoplasmic ratio is calculated from data obtained from the same cell, it is independent of these potential variations.
Data analysis
Data are presented as mean Ϯ sem. For the Northern blot experiments, n refers to the number of times an experiment was repeated, and each experiment represents a separate pool of dispersed pituitary cells. For the immunofluorescence experiments, n refers to the number of single cells examined. Each treatment group reflects coverslips from three or more separate pools of dispersed pituitary cells; however, for the selected data used for intensity analysis, the data were derived from 2-5 fields/treatment group. In some cases, the t distribution was used to test the hypothesis that the response was significantly different than 100%. All other statistical analyses were done using SigmaStat (SPSS, Inc., Chicago, IL). For multiple comparisons, differences between groups were determined by ANOVA and the Student-Neuman-Keuls method; where differences are indicated as being significant, P Ͻ 0.05. For the ratio data presented (see Table 2 ), the treatment groups had unequal variances; therefore, ANOVA on ranks and Dunn's test for multiple comparisons were used.
Results

Pituitary expression of PR mRNA
Poly(A ϩ ) RNA from cultured rat anterior pituitary cells revealed multiple PR mRNA species between 4.8 -10.2 kb, with transcripts corresponding to approximately 10.1 and 5.1 kb being the most abundant (Fig. 1 ). For comparison, poly(A ϩ ) RNA samples prepared from anterior pituitary and uterine tissue samples are included in Fig. 1 . There are no apparent differences in relative size of pituitary PR mRNA species from in vitro, compared with in vivo, samples. Among the multiple RNA species displayed in the uterine samples, the most abundant transcripts were approximately 10.1 and 5.8 kb (Fig. 1) . The finding of multiple transcripts is in general agreement with reports for tissues (including those from human, rat, mouse, rabbit, and chicken) and cell types analyzed by Northern blot using cDNA-derived probes, although the functional significance of multiple PR mRNA transcripts has not been precisely determined (16 -22) . Whether variations in the size and the number of reported transcripts is related to differences in functional expression or to methodological differences, e.g. in cDNA probes, has not been established. Fig. 1 , however, which shows the results using the same probe for rat pituitary and uterus, suggests that the expression of certain PR mRNA transcripts could be tissue specific.
Effects of E 2 and progesterone on expression of pituitary PR mRNA
To establish whether estrogen could induce PR message in anterior pituitary cells in vitro, we used cells from ovariectomized rats cultured plus or minus E 2 . As shown in a representative Northern blot in Fig. 2A, 3 days of E 2 treatment in culture leads to a marked increase in steady-state levels of PR mRNA in pituitary cells. The E 2 -induced increase was 5-to 6-fold: in the absence of estrogen, PR mRNA levels are 19 Ϯ 7% for the 5.1-kb transcript and 15 Ϯ 5% for the 10.1-kb transcript, relative to that found for the E 2 -treated group (n ϭ 4). We next questioned whether progesterone could modulate PR mRNA levels in E 2 -treated pituitary cells. Analysis of steady-state levels of the predominant transcripts shows that, by as little as 3 h of progesterone exposure, there is a significant decrease in the approximately 10.1-kb fragment and that the depression remains over the next 6 h. By 12 h of progesterone treatment, there is an apparent recovery, with the PR mRNA levels not significantly different than in the estrogen-only group, although there was considerable variability within the 12-h group (Fig. 2B) . For the approximately 5.1-kb transcript, the pattern was similar, but there was less of a decline associated with progesterone treatment, and the first significant decrease was not observed until 6 h; by 12 h, the recovery was complete (Fig. 2C ). Whether this difference in temporal pattern between two PR mRNA transcripts has functional consequences, e.g. leading to alterations in the translation and ratio of the protein isoforms of PR, is not known. Overall, however, these data show that progesterone treatment of cultured rat pituitary cells can lead to a reversible decrease in steady-state levels of PR mRNA.
Distribution of pituitary PR protein and effect of E 2
The aims of the next series were to examine the effect of estrogen on PR protein and the distribution of PR, relative to LH in cultured anterior pituitary cells, using dual label immunocytochemistry. As presented in Fig. 3 and Table 1 , nuclear PR essentially is undetectable by immunofluorescence in anterior pituitary cells cultured in the absence of estrogen (panel b), but strong PR immunoreactivity is found after 3 days of E 2 treatment (panel e). To determine the extent of colocalization of PR with gonadotropes, we used LH immunoreactivity as a marker. Under our conditions, LH-positive cells represent 7-8% of the total cells, which is in general agreement with that reported for pituitaries from intact females but lower than reported for pituitaries from longerterm ovariectomized rats (37). We found no significant differences in the percent of LH-positive cells related to the presence or absence of E 2 in the culture medium (Table 1) . When cells are exposed to E 2 , essentially all of the LH-positive cells are also positive for PR (Fig. 3 , panels d and e; also see Fig. 4 ). Of the nearly 300 cells identified as PR-immunopositive, only four did not colocalize with LH immunoreactivity (Table 1) ; the possibility that these cells were gonadotropes expressing only FSH was not investigated.
Effect of progesterone on pituitary PR protein
Because of the marked effect of acute progesterone treatment on PR mRNA in cultured pituitary cells, we examined PR protein, as determined by dual immunofluorescence under similar experimental conditions. As presented in Table 1 , the addition of progesterone to the medium for varying duration did not significantly affect either the percent of LH cells identified as positive for PR, or the percent of pituitary cells negative for LH but positive for PR immunoreactivity. The scoring for this analysis was based on a simple yes/no determination of PR immuno- reactivity without regard for potential gradations in staining intensity. When the pattern and intracellular distribution of PR immunoreactivity is examined, a more complex result is obtained. As shown in Fig. 4 , gonadotropes exhibit the characteristic predominant nuclear staining for PR in the presence of E 2 . When the cells are exposed to progesterone, there seems to be a gradual increase in cytoplasmic staining, particularly after 9 and 12 h of progesterone treatment (panels h and j). All gonadotropes, however, did not follow the same temporal pattern of apparent changes in PR staining intensity; for example, in panel h, two of the three cells exhibit distinct cytoplasmic PR staining, whereas a third gonadotrope in the field shows the characteristic predominant nuclear PR staining similar to that found in the absence of progesterone (compare with panel b).
To quantitatively assess the distribution of PR, we analyzed the staining intensity in the cytoplasm and the nucleus (Table 2 ). In the absence of progesterone, the high ratio of nuclear to cytoplasmic staining intensity is consistent with the previously reported predominant nuclear localization of the PR. When cells are incubated in the presence of progesterone, there is a gradual change, over time, in the PR staining intensity in the two compartments, such that by 9 h and 12 h, the nucleus-to-cytoplasm ratio is significantly decreased to near unity. Examination of the individual compartmental changes shown in Table 2 suggests that the decrease in the ratio is caused, at least in part, by a gradual increase in PR staining intensity in the cytoplasm, which is significant by 12 h of progesterone exposure. The nuclear compartment shows a more complex pattern; in comparing the groups that were incubated with progesterone for varying durations, we found that nuclear PR staining intensity significantly decreased by 9 and 12 h, compared with that found for cells exposed to progesterone for 3 h.
Discussion
Progesterone has a role, at the level of the pituitary gland, in regulating the magnitude and possibly the termination of the preovulatory gonadotropin surge leading to ovulation (24, 27-31). To what extent this biphasic action of progesterone is dependent upon alterations in expression of PR mRNA, and even PR protein isoforms, is not known. There is evidence, however, for E 2 up-regulation and chronic progesterone down-regulation of PR message in monkey pituitaries (15) , and Szabo et al. have preliminary evidence that estrogen increases rat pituitary PR mRNA (38). We report here that, indeed, estrogen does up-regulate and, further, that progesterone can acutely down-regulate rat pituitary PR mRNA levels.
Concomitant with the onset of the preovulatory gonadotropin surge is an acute rise in progesterone that extends past the termination of the LH surge and that has a duration of about 12 h in rats (28, 39). The pituitary is prepared for this almost 10-fold increase in progesterone; early reports suggested that pituitary PR protein content is highest in tissue taken from proestrous rats (11, 40) and that the pituitary PR protein in vivo is induced by estrogen (7, 9, 11) . We now show that E 2 induction of pituitary PR occurs in vitro for mRNA and for protein and that PR protein essentially localizes exclusively to the gonadotrope. The finding of colocalization of PR with LH cells is consistent with that reported for intact tissue (6) . At the other end of the preovulatory rise in progesterone, is the decrease in pituitary PR abundance on estrus a consequence of progesterone? Whether, in general, progesterone can down-regulate its own receptor has been a difficult experimental question because of a variety of tissue and even cell specificities and because of the complexity associated with the ability of progesterone to interfere with estrogen's action in some tissues. For the rat pituitary gland, results from early studies, using exchange assays, are conflicting but suggest that progesterone treatment in vivo is related to a transient increase in nuclear PR within 1-2 h (11, 12) and to a decrease in cytosolic PR at 24 h, possibly attributable to a suppression of estrogen's action (9, 12) . For the monkey pituitary, extended progesterone treatment in vivo (14 days) suppressed PR mRNA (15) , but the effect on PR protein was variable (5, 14) . Our results for rat pituitary cells in vitro establish that progesterone exposure can lead to a reduction b Cells cultured in the absence of E 2 ; the percent of LH-positive cells among the Prog-treated groups (3, 6, 9 , and 12 h) were combined (no significant differences among groups).
of about 50% in steady-state PR mRNA levels by 6 h. This is of interest, in light of reports that the ability of progesterone to augment GnRH-stimulated LH secretion only occurs within a narrow window of about 1-6 h of exposure to progesterone (24, 29) and is consistent with the temporal relationship between progesterone and LH secretion during the preovulatory period. Whether the restricted time course for the progesterone stimulatory action is caused simply by a diminution in the number of available PRs or, more likely, by a combination of possible mechanisms, including a progesterone-induced decrease in GnRH receptors (30) and an alteration in the ratio of the various isoforms (A, B, and possibly C) of the PR and a decrease in PRs remains to be determined.
The restoration of PR message levels by 12 h of progesterone exposure in cultured pituitary cells is less easy to reconcile with in vivo events, given that the number of PRs is reported to be reduced on estrus, compared with proestrus (11, 40) . One difference between the in vitro model used for this study and the case in vivo is that the pituitary cells in vitro were in the continual presence of E 2 during exposure to progesterone. On proestrus, once the gonadotropin surge is initiated and while progesterone levels are rising, E 2 levels drop precipitously and are at their nadir by the end of proestrus and during estrus, thus allowing progesterone to exert its effect in the relative absence of E 2 (39, 41). There is little direct information available on progesterone modulation of estrogen receptor message or interference with estrogen's action in adult pituitary cells, although there is a report that progesterone treatment had no consistent effect on pituitary estrogen receptor mRNA isoforms (42). Taken together, one interpretation of our results is that, under these temporal conditions, progesterone does not substantially interfere with estrogen's action and that the restoration of PR message levels at 12 h reflects an E 2 -induced wave of activity after the earlier progesterone-induced down-regulation of PR mRNA. The cultured pituitary cell model could be useful to directly test whether progesterone does indeed affect estrogen's regulation of PR in the gonadotrope.
Consistent with the observed change in steady-state PR mRNA levels at 12 h, we found an increase in cytosolic PR protein that could be interpreted as reflecting an increase in PR synthesis. This speculation is based on our use of the immunofluorescence approach for assessing PR, which allows for localization of the protein in situ without cell fractionation and also for the manipulation of progesterone levels without compromising the assay-detection system. PR mRNA stability and protein half-life certainly contribute to the observed changes in PR levels, but no information on these variables is available for gonadotropes. In T47D human breast cancer cells, the half-life of PR mRNA was estimated at 2-2.5 h and to be unaffected by the presence of progesterone (43); a 21-h half-life was estimated for PR protein, with a reduction to 6 h in the presence of a progesterone analog (44) and a requisite 8 h or more before cytoplasmic replenishment is observed after progesterone-induced nuclear processing (45). These studies generally support our speculation regarding synthesis of PR in pituitary cells, but comparisons between dividing cells and terminally differentiated cells are difficult, because of the influence of cell cycle on kinetic estimates for the tumor cells.
In summary, we show that E 2 increases steady-state levels of PR mRNA and PR protein in cultured rat gonadotropes and that exposure to progesterone leads to a rapid, but transient, down-regulation of PR message and a change in PR protein distribution in these cells. The time course of the observed progesterone effect is significant for its concordance with the temporal context associated with rat preovulatory gonadotropin secretion.
